Keros Therapeutics, Inc. (KROS)

Keros Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	559.93	331.15	279.05	230.04	265.88
Cash & Short-Term Investments	559.93	331.15	279.05	230.04	265.88
Cash Growth	69.09%	18.67%	21.30%	-13.48%	3687.41%
Accounts Receivable	2.74	0.14	-	18	-
Other Receivables	1.71	0.95	0.84	0.2	0.22
Receivables	4.46	1.09	0.84	18.2	0.22
Prepaid Expenses	1.73	1.64	2.28	1.38	0.97
Other Current Assets	22.77	13.42	3.6	1.82	0.66
Total Current Assets	588.89	347.29	285.77	251.44	267.73
Property, Plant & Equipment	23.49	19.47	17.57	2.4	1.6
Other Long-Term Assets	3.51	3.26	3.45	1.41	0.12
Total Assets	615.89	370.03	306.78	255.25	269.44
Accounts Payable	4.6	5.45	3.34	3.65	2.15
Accrued Expenses	20.45	17.25	12	7.03	4.21
Current Portion of Leases	1.98	1.01	0.46	0.86	0.42
Current Income Taxes Payable	-	-	-	0.11	0.19
Other Current Liabilities	0.42	0.67	0.75	0.2	0.22
Total Current Liabilities	27.45	24.37	16.55	11.85	7.18
Long-Term Leases	16.88	13.44	12.81	0.23	0.48
Other Long-Term Liabilities	-	-	-	-	0.06
Total Liabilities	44.33	37.81	29.36	12.08	7.72
Common Stock	0	0	0	0	0
Additional Paid-In Capital	1,140	713.64	505.86	366.93	326.73
Retained Earnings	-568.78	-381.43	-228.43	-123.76	-65.01
Total Common Equity	571.55	332.21	277.42	243.17	261.72
Shareholders' Equity	571.55	332.21	277.42	243.17	261.72
Total Liabilities & Equity	615.89	370.03	306.78	255.25	269.44
Total Debt	18.86	14.44	13.27	1.09	0.9
Net Cash (Debt)	541.07	316.7	265.78	228.95	264.98
Net Cash Growth	70.84%	19.16%	16.09%	-13.60%	33483.90%
Net Cash Per Share	14.45	10.75	10.53	9.81	17.09
Filing Date Shares Outstanding	40.56	35.98	28.54	24	23.27
Total Common Shares Outstanding	40.55	31.84	27.54	23.97	23.19
Working Capital	561.44	322.92	269.22	239.59	260.54
Book Value Per Share	14.09	10.43	10.07	10.14	11.28
Tangible Book Value	571.55	332.21	277.42	243.17	261.72
Tangible Book Value Per Share	14.09	10.43	10.07	10.14	11.28
Machinery	7.19	5.85	2.97	1.92	1.19
Leasehold Improvements	-	-	0.21	0.26	0.26

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q